Summary
The clinical usefulness of serum pancreatic secretory trypsin inhibitor (PSTI) in pancreatic disease and gastric and colorectal cancer has been examined.
The results showed that serum PSTI in acute pancreatitis was significantly higher than in normal subjects and it was also raised in acute exacerbations of chronic pancreatitis. Although the sensitivities of serum PSTI, amylase and elastase I were similar, serum PSTI in necrotizing hemorrhagic pancreatitis was 2.7 times higher than in mild acute pancreatitis. Only a few patients with chronic pancreatitis showed increased concentrations and the mean value was near normal.
The mean PSTI in patients with pancreatic and colorectal cancer was higher than normal, although that of gastric cancer was within normal limits. The sensitivity of serum PSTI measurements in patrents with these three malignant diseases was only about 30%.
The results suggested that the measurement of serum PSTI could be useful in the diagnosis of acute pancreatitis, but of limited value in the diagnosis of other disease which we examined.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kazal LA, Spicer DS, Brakinsky RA. Isolation of a crystalline trypsin inhibitor/anticoagulant protein from pancreas. J Am Chem Soc 1948; 70:3034–3048.
Kitahara T, Takatsuka Y, Fugimoto K, Tanaka S, Ogawa M, Kosaki G. Radioimmunoassay for human pancreatic secretory trypsin inhibitor: Measurement of serum pancreatic secretory trypsin inhibitor in normal subjects and subjects with pancreatic disease. Clin Chim Acta 1980;103:135–143.
Eddeland A, Ohlsson K. A radioimmunoassay for measurement of human pancreatic secretory trypsin inhibitor in different body fluid. Hoppe Seyler's L Physiol Chem 1978;359:671–675.
Matsuda K, Ogawa M, Murata A, Kitahara T, Kosaki G. Elevation of serum immunoreactive pancreatic secretory trypsin inhibitor contents in various malignant disease. Res Commun Chem Pathol Pharmacol 1985;40:301–305.
Renner IG, Rinderknecht H, Douglas AP. Profiles of pure pancreatic secretion in patients with acute pancreatitis. The possible role of proteolytic enzymes in pathogenesis. Gastroenterology 1978;75:1090–1098.
Allan BJ, Tournet R, White TT, Intraductal activation of pancreatic zymogens behind a carcinoma of the pancreas. Gastroenterology 1978;75:1090–1098.
Greene LJ, Giordans Jr JS. The structure of the bovine pancreatic secretory trypsin inhibitor-Kazal inhibitor. I. Isolation and amino acid sequences of the tryptic peptide from reduced aminoethylated inhibitor. J Biol Chem 1969;224:285–298.
Eddeland A, Ohlsson K. Purification of canine pancreatic secretory trypsin inhibitor and interaction in vitro with complexes of trypsin-α-macroglobulin. Scand J Clin Lab Invest 1976;46:815–820.
Adham M, Dyce B, Wilding P, Wong T, Haverback BJ. Trypsin binding {ie331-1} patients with acute pancreatitis. Clin Res 1967;15:128.
Eddeland A, Ohlsson K. Studies on the pancreatic secretory trypsin inhibitor in plasma and in complex with trypsin in vivo and in vitro. Scan J Clin Lab Invest 1978;38:507–513.
Eddeland A, Ohlsson K. The elimination in dogs of {ie331-2} complex inactivated by the Kazal or the Kunitz inhibitor. Hoppe-Seyler's L Physiol Chem 1978;359:379–384.
Marks WH, Ohlsson K. Elimination of pancreatic secretory trypsin inhibitor from the circulation. A study in man. Scand J Gastroenterol 1983;18:955–959.
Otsuki M, Oka T, Suehiro I, Okabayashi Y, Ohki A, Yuu H, Baba S. Serum pancreatic secretory trypsin inhibitor in acute pancreatitis. Lancet 1980;20:205.
Hunt LT, Barker WC, Dayhoff MO. Epidermoid growth factor: internal duplication and probable relationship to pancreatic secretory trypsin inhibitor. Biochem Biophys Res Commun 1974;60:1020–1028.
Scheving LA. Primary aminoacid sequence similarity between human epidermal growth factor-urogastrone. Human pancreatic secretory trypsin inhibitor and members of porcine secretin family. Arch Biochem Biophys 1983;226:411–413.
Ogawa M, Pancreatic secretory trypsin inhibitor—a historical review. The biliary Tract and Pancreas 1986;7:1–7.
Ogawa M, Malignant tumor and serum PSTI: Production and mechanism of PSTI in malignant tumor. In: Kosaki G, Ogawa M, eds. Pancreatic Secretory Trypsin Inhibitor Igakutoshoshupan Tokyo 1985;217–220.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Satake, K., Inui, A., Sogabe, T. et al. The measurement of serum immunoreactive pancreatic secretory trypsin inhibitor in gastrointestinal cancer and pancreatic disease. Int J Pancreatol 3, 323–331 (1988). https://doi.org/10.1007/BF02788466
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02788466